Cordis logo

Cordis

North America, Florida, United States, Hialeah

Description

Cordis Corporation, a Johnson & Johnson company, has pioneered less invasive treatments for vascular disease.

Investor Profile

Cordis has made 2 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Clinical Trials
  • Medical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cordis frequently co-invest with?

415 Capital
Europe, Bayern, Germany, Munich
Co-Investments: 1
Panakes Partners
Europe, Lombardia, Italy, Milano
Co-Investments: 1
S3 Ventures
North America, Texas, United States, Austin
Co-Investments: 1
Sante Ventures
North America, Texas, United States, Austin
Co-Investments: 2
M&L Healthcare Investments
Asia, Central Region, Singapore, Singapore
Co-Investments: 1

What are some of recent deals done by Cordis?

Endovascular Engineering

Menlo Park, California, United States

Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions.

Clinical TrialsMedicalMedical Device
Series BFeb 18, 2025
Amount Raised: $42,000,000
Endovascular Engineering

Menlo Park, California, United States

Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions.

Clinical TrialsMedicalMedical Device
Series AApr 5, 2022
Amount Raised: $15,000,000